Translational regulation is critical in cancer development and progression. Translation sustains tumor growth and development of a tumor vasculature, a process known as angiogenesis, which is activated by hypoxia. Here we first demonstrate that a majority of large advanced breast cancers overexpress translation regulatory protein 4E-BP1 and initiation factor eIF4G. Using model animal and cell studies, we then show that overexpressed 4E-BP1 and eIF4G orchestrate a hypoxia-activated switch from cap-dependent to cap-independent mRNA translation that promotes increased tumor angiogenesis and growth at the level of selective mRNA translation. Elevated levels of 4E-BP1 trigger hypoxia inhibition of cap-dependent mRNA translation at high-oxygen levels and, with eIF4G, increase selective translation of mRNAs containing internal ribosome entry sites (IRESs) that include key proangiogenic, hypoxia, and survival mRNAs. The switch from cap-dependent to cap-independent mRNA translation facilitates tumor angiogenesis and hypoxia responses in animal models.
INTRODUCTION
Translational regulation plays a key role in cancer development and progression, impacting on tumor cell proliferation and growth, response to stresses such as hypoxia, and stimulation by mitogenic signals and cell hormone receptors (Schneider and Sonenberg, 2007) . The ability of the translation machinery to load ribosomes onto mRNAs via the m 7 GTP cap is a primary point of control and stratifies mRNAs into those that are cap dependent and highly regulated, from cap-independent mRNAs that utilize an internal ribosome entry site (IRES) within the 5 0 untranslated region (Hellen and Sarnow, 2001) , thereby bypassing translation inhibition during hypoxia (Holcik and Sonenberg, 2005) . Cap-dependent mRNAs acquire ribosomes and initiate translation through interaction with the cap-dependent initiation complex eIF4F, comprised of the 5 0 cap-binding protein eIF4E, scaffold protein eIF4G, and ATP-dependent helicase eIF4A (Gingras et al., 1999) . Formation of eIF4F, its interaction with mRNAs, and its ability to facilitate translation initiation are controlled by the eIF4E sequestering proteins, of which 4E-BP1 is the major form (Gingras et al., 1999) . 4E-BP1 is maintained in the inactive (hyperphosphorylated state) by the kinase mTOR but is activated during stresses such as hypoxia when mTOR activity is reduced (Connolly et al., 2006; Holcik and Sonenberg, 2005) . Hypophosphorylated (activated) 4E-BP1 sequesters eIF4E, thereby suppressing cap-dependent mRNA translation and promoting translation of IRES-containing mRNAs (Svitkin et al., 2005) . Many IRES mRNAs are thought to initiate with a subset of factors mediated by eIF4G-IRES interaction (Hellen and Sarnow, 2001) . Importantly, some cellular mRNAs can utilize a dual mechanism of initiation (cap or IRES); these include those that orchestrate angiogenesis (VEGF-A), hypoxia responses (transcription factor HIF1a) (Lang et al., 2002) , and inhibition of apoptosis (Bcl2) (Sherrill et al., 2004) among others.
Tumor progression requires the development of a tumor vasculature, which is generally induced in response to tumor hypoxia through a process known as an angiogenic switch (Bergers and Benjamin, 2003) . Tumor angiogenesis is rate limiting for tumor growth and regulated at multiple levels of gene control, including mRNA translation (Bergers and Benjamin, 2003) . Angiogenesis is also thought to be dynamic: as tumor volume expands, hypoxia increases and triggers additional vascularization through elevated expression of VEGF and other proangiogenic factors, partially restoring oxygen to the growing tumor edge, which is repeated as the tumor continues to grow (Bergers and Benjamin, 2003) .
Here we show that 4E-BP1 and eIF4G are strongly overexpressed in the majority of human large advanced tumors of the breast, known as locally advanced breast cancers (LABC). Using breast cancer cell and tumor models, we show that, together, overexpressed 4E-BP1 and eIF4G function as a hypoxia-activated switch to facilitate capindependent mRNA translation, promoting translation of IRES-containing mRNAs that promote tumor survival and angiogenesis. These data suggest that, in addition to tumor models with overexpression of eIF4E and increased capdependent mRNA translation, a second translational control pathway exists that stimulates cap-independent mRNA translation of select mRNAs involved in tumorigenesis.
RESULTS

Expression Levels of Cap-Dependent Translation Initiation Factors in Breast Cancer
We first examined by immunohistochemistry (IHC) the expression levels of key factors that comprise or regulate the cap-dependent mRNA initiation complex in normal breast specimens and pretreatment tumor biopsies of invasive ductal carcinomas, the most common form of breast cancer in women ( Figure 1A ). All antibodies used in this study were optimized for IHC, and there was no background staining if the primary antibody was omitted (data not shown). Immunoblot analysis of equal amounts of protein extracted from normal breast epithelium and a posttreatment LABC surgical tumor specimen demonstrated strong and specific binding to respective targets ( Figure 1B ). eIF4E levels were moderately elevated in 60% and strongly elevated in 20%-25% of tumors of 1 to <5 cm in size (T1-T2 tumors) ( Figure 1A and Table  S1 , in the Supplemental Data available with this article online) and did not significantly increase thereafter with further increased tumor size (>5 cm, T3) (p = 0.0017). Thus, eIF4E is moderately elevated in more than half of the smaller invasive ductal carcinomas and strongly elevated in roughly one-quarter of them. Surprisingly, 4E-BP1, a negative regulator of cap-dependent mRNA translation, was markedly overexpressed in tumors >5 cm in size, increasing from 22% among small tumors to 63% in large tumors (>5 cm, T3, p = 0.0011) and 71% of LABC tumors (p = 0.0013) ( Figure 1A and Table S1 ). Initiation factor eIF4G was also strongly increased in LABC tumors (52%) compared to small tumors (T1, 11%) ( Figure 1A and Table S1 , p = 0.0023). A future report will present clinical associations between overexpression of 4E-BP1 and eIF4G with tumor histological-grade, lymph node involvement, disease progression, and other disease parameters. Levels of initiation factor eIF4A were unchanged between normal and tumor breast tissues ( Figure 1C ). We did not further pursue studies involving eIF4E because it's increased expression was not associated with large tumor size.
We could not determine 4E-BP1 phosphorylation status in tumor cells by IHC due to unacceptable background staining and variability due to tissue processing differences. Such staining has been reported by others but generally without matching data on 4E-BP1 abundance (Kremer et al., 2006; Zhou et al., 2004; Castellvi et al., 2006; Petricoin et al., 2007; Rojo et al., 2007) . However, decreased mTOR Ser2448 phosphorylation (a surrogate for loss of mTOR activity) determined in hypoxic regions of tumors by IHC also suggests that 4E-BP1 is likely activated (dephosphorylated) in the hypoxic growing edge of tumors (Kaper et al., 2006 and data not shown), suggesting a dynamic role for mTOR/4E-BP1 activity in cancer development. The large LABC tumor specimens studied here were highly hypoxic, as shown by increased abundance of HIF1a ( Figure S1A ).
Increased Expression of 4E-BP1 and eIF4G
Promotes Translation of VEGF mRNA during Hypoxia The human breast cancer specimens examined above suggest a significant association between overexpression of 4E-BP1 and eIF4G with large tumor size in breast cancer but cannot address a possible function. To determine the function of increased expression of 4E-BP1 and eIF4G in protein synthesis during hypoxia, angiogenesis, and tumor formation, a panel of transformed invasive ductal carcinoma cell lines was used. The lines consisted of MCF10A cells (immortalized human breast epithelial cells), CRL1902 cells (early stage-derived primary breast cancer cells), and BT474 cells (late stage-derived highly transformed breast cancer cells) (Lasfargues et al., 1978) . Immunoblot analysis of equal amounts of protein, which was the same as equal numbers of cells, demonstrated 2-fold increased levels of eIF4E and up to 3-fold higher levels of eIF4G with increasing transformation (Figure 2A ), similar to that of human tumor specimens. 4E-BP1 levels were 3-fold lower in highly transformed BT474 cells compared to the less transformed cell lines but retained rapamycin-sensitive activation (hypophosphorylation) (Figure 2A ). There was no change in other core members of the cap-dependent initiation complex, including eIF4A and poly(A) binding protein (data not shown), or of b-tubulin protein (shown). We therefore used these breast cancer cell lines to examine the functional importance of increased expression of 4E-BP1 in translation, angiogenesis, and tumor formation.
BT474, CRL1902, and MCF10A breast cancer cells were engineered to stably overexpress by 4-fold (similar to human LABC tumors based on IHC; data not shown) a wild-type HA-epitope tagged 4E-BP1 or a deletion mutant (D4E-BP1) that cannot bind eIF4E ( Figure 2B ). D4E-BP1 fails to enhance cap-independent mRNA translation during hypoxia (Connolly et al., 2006) . Overexpression of wild-type or mutant D4E-BP1 had little effect on overall normoxic (20% O 2 ) protein synthesis rates in all cell lines when comparing equal protein amounts ( Figure 2C ). In BT474 cells, which are largely resistant to moderate, but not strong (0.5% O 2 , 24 hr), hypoxia downregulation of protein synthesis was rendered 40% more sensitive by overexpression of wild-type 4E-BP1, but not by D4E-BP1 ( Figure 2C ). However, overexpression of 4E-BP1 in hypoxic BT474 cells upregulated VEGF mRNA translation by 5-fold compared to 1.5-fold for the control, with no increase for D4E-BP1 ( Figure 2D ), when normalized to equal VEGF mRNA levels ( Figure 2E ). VEGF mRNA levels were increased 30% in BT474 cells under hypoxia regardless of wild-type or mutant 4E-BP1 protein overexpression ( Figure 2E ). Similar VEGF mRNA results were found in CRL1902 and MCF10A cells (data not shown). Wild-type 4E-BP1 overexpression increased VEGF-specific mRNA translation during hypoxia by 2.5-fold in CRL1902 cells and only slightly in MCF10A cells, possibly due to the lower levels of eIF4G in these less transformed cells ( Figure 2F ). Indeed, stable reduction of BT474 eIF4G levels by gene silencing to that of immortalized MCF10A cells ( Figure 2F ) eliminated the strong hypoxia-induced translation of VEGF mRNA in 4E-BP1 overexpressing BT474 cells ( Figure 2G , p < 0.05) but only reduced overall protein synthesis by 15% at normal oxygen levels. eIF4G silencing did not further impair protein synthesis during hypoxia (0.5% O 2 , 24 hr), compared to control, nonsilenced cells ( Figure 2H ). HIF1a mRNA translation during hypoxia was also more strongly stimulated by overexpression of wild-type 4E-BP1 in BT474 than MCF10A cells ( Figure S1B ). Bcl2 expression was slightly (2-to 3-fold) increased and was sustained in 4E-BP1 overexpressing MCF10A cells during hypoxia ( Figure S1B ), consistent with these results.
Elevated Levels of 4E-BP1 Comprise a Hypoxia-Activated Translation Switch
Increased expression of 4E-BP1 could provide a switch from cap-dependent to cap-independent (IRES-mediated) mRNA translation (Svitkin et al., 2005) , which is activated by hypoxia (Connolly et al., 2006) . To investigate this possibility, BT474 cells overexpressing wild-type or D4E-BP1 were transfected with plasmids expressing bicistronic mRNA reporters containing a cap-dependent Renilla luciferase and a downstream Firefly luciferase, controlled by either the VEGF-A ( Figure 3A ), HIF1a (Figure 3B ), or EMCV IRES ( Figure 3C ) or a cap-dependent 5 0 NCR sequence described previously (Lang et al., 2002) . Translation rates during normoxia and hypoxia were determined by quantifying the levels of the two different forms of luciferase, normalized to equal mRNA levels. Increased levels of wild-type 4E-BP1 stimulated translation directed by the VEGF IRES by >5-fold under hypoxia while impairing cap-dependent translation by 1.5-fold ( Figure 3A ). Proof of cap-dependent and HIF1a or VEGF-IRES-dependent translation by these elements is shown by control studies in which monocistronic mRNAs were expressed with and without a 5 0 stable hairpin upstream of either element or with deletion of the IRES ( Figure S1C ). Hypoxia also did not alter the size of the monocistroinic mRNAs (data not shown). The hairpin blocked luciferase translation from the cap-dependent, but not the IRES, element under normoxic and hypoxic conditions, whereas deletion of the IRES blocked luciferase translation during hypoxia.
Increased levels of 4E-BP1 also stimulated HIF1a IRESdirected translation by 3-fold ( Figure 3B ) and that of the EMCV IRES, a control viral IRES, by 8-fold while impairing their respective cap-dependent translation activities ( Figure 3C ). Bcl2 IRES translation was sustained (but not increased) during hypoxia inhibition of protein synthesis by 4E-BP1 with eIF4G overexpression (Figure S2A ), and no alternatively spliced mRNA forms were detected (data not shown). To directly visualize the translation switch from cap to IRES mediated by 4E-BP1 and eIF4G, vector control and 4E-BP1 overexpressing BT474 cells were transfected with a plasmid expressing a bicistronic mRNA in which the luciferase open reading frames were replaced with a cap-dependent red fluorescent protein (RFP) and a VEGF IRES-dependent green fluorescent protein (GFP) ( Figure 3D ). Compared to vector control cells, 4E-BP1 cells expressed a 4-fold increased level of VEGF IRES-dependent GFP compared to cap-dependent RFP under hypoxia (0.5% O 2 , 24 hr) ( Figure 3D , right panel). Increased expression of 4E-BP1 therefore acts as a hypoxia-inducible switch, promoting cap-independent over cap-dependent translation.
Increased 4E-BP1 Levels Trigger Disassembly of Cap-Dependent Initiation Complexes with Only Moderate Oxygen Depletion
The integrity of cap-dependent initiation complexes was investigated under conditions of increasing deprivation of oxygen in control and 4E-BP1 overexpressing cells. Proteins associated with eIF4E by retention on m 7 GTPSepharose were analyzed by immunoblot analysis ( Figure 3E ). In control cells, cap-dependent initiation complexes were incompletely disrupted by 4E-BP1 displacement of eIF4E at 2% O 2 and largely disrupted at 0.5% O 2 . In cells overexpressing 4E-BP1, initiation complexes were almost fully disrupted at 2% O 2 . Increased expression of 4E-BP1 therefore decreases by 5-fold the level of O 2 deprivation required to provoke stronger disassembly of 
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Cap-Independent Translation in Tumor Angiogenesis cap-initiation complexes. When normalized to equal VEGF-A mRNA levels, 4E-BP1 overexpressing cells increased VEGF protein synthesis by 3.5-fold at 10-fold-less oxygen deprivation (5% O 2 ) than required in control cells (0.5% O 2 ) to yield a smaller (2-fold) increase ( Figure 3F ).
Increased Expression of 4E-BP1 and eIF4G Promotes IRES-Dependent VEGF mRNA Translation and Tumor Vascularization in a Tumor Angiogenesis Model
We examined the effect of 4E-BP1/eIF4G on VEGF expression and tumor vascularization in an angiogenesis model system. BT474 cells overexpressing vector control, wild-type, or D4E-BP1 were implanted into the chick chorioallantoic membrane (CAM) of the 10-day-old chick embryo (Brooks et al., 1994) and allowed to grow for 7 days ( Figure 4A , upper panels). Angiogenesis of the CAM by this time is a measurement of tumor-directed vascularization (Brooks et al., 1994) . CAM tumors derived from 4E-BP1 overexpressing BT474 cells ( Figure 4A ) showed a 3-fold higher density of vascularization (30%) compared to vector control (8%) or the D4E-BP1 mutant (<5%) ( Figure 4B , p < 0.001). Results obtained using CRL1902 cells, engineered to express similarly increased levels of 4E-BP1 but which express lower levels of eIF4G, showed a more modest increase in tumor angiogenesis ( Figures  4A and 4B , 7% versus 13%, p < 0.01). There was no significant effect on angiogenesis in MCF10A cells ( Figures  4A and 4B) . In situ staining with FITC-tomato lectin, to visualize the luminal surface of blood vessels (Hangai et al., 2002) , demonstrated that vessels in tumors overexpressing wild-type 4E-BP1 were significantly larger, more irregularly shaped, and leaky compared to that of vector control tumors ( Figure 4C ). Because most VEGF in the CAM tumor at this time is tumor derived (Brooks et al., 1994) , VEGF-A levels in the tumor CAM were determined by immunoblot analysis of equal amounts of CAM protein lysate ( Figure 4D ), demonstrating a 2.5-fold increase in VEGF-A levels from wild-type 4E-BP1 samples. High-resolution electrophoretic analysis of 4E-BP1 protein indicated that 70% was in the hypophosphorylated (activated) form in CAM tumors, consistent with the ability to downregulate cap-dependent translation by sequestration of eIF4E.
Tumor growth in the CAM showed that 4E-BP1 overexpressing BT474 cell tumors were almost 150% larger after 8 days of growth compared to vector or D4E-BP1 mutant controls ( Figure 4E , p < 0.01), whereas 4E-BP1 CRL1902 cell tumors increased by 50% compared to controls (p < 0.05), and MCF10A cell tumors by < 25% (p < 0.05). Thus, increased expression of 4E-BP1 promotes angiogenesis and vascular density, in conjunction with increased levels of eIF4G.
The importance of 4E-BP1, eIF4G, and eIF4E in promoting tumor angiogenesis was also investigated in MDA-MB435 breast cancer cells by silencing their expression. Expression of 4E-BP1, eIF4G, or eIF4E was reduced by 60%-80% using stable transformed lentivirus shRNA vectors without an effect on nontargeted eIF4A or eIF4B levels ( Figure 5A ). The reduction of eIF4G or eIF4E resulted in only a 15%-20% decrease in overall protein synthesis rates (data not shown), consistent with the results of Figure 2C . Compared to control tumors when implanted into the CAM of 10-day-old chick embryos, tumor angiogenesis was reduced by 35% with silencing 4E-BP1, 60% with eIF4G, and 25% with eIF4E silencing ( Figures  5B and 5C ). The silencing of eIF4G also most significantly reduced VEGF production and tumor growth compared to eIF4E silencing, consistent with the importance of IRESdirected VEGF mRNA translation ( Figures 5D and 5E ).
Increased Expression of 4E-BP1 and eIF4G
Promotes Tumor Growth, IRES-Dependent Translation, and Angiogenesis in an Animal Model Studies next determined whether IRES-directed expression of VEGF increases tumor angiogenesis and growth in a mouse tumor model. Female mice at 6 weeks of age were implanted subcutaneously in the flank with equal numbers of vector control or 4E-BP1 overexpressing BT474 cells. Primary tumor growth was promoted 2.5-fold over a period of 3 weeks by 4E-BP1 (Figures 5F and 5G, p < 0.001). D4E-BP1 tumors were very small, regressed within 2 weeks, and could not be studied further (data not shown). Neither unmodified nor 4E-BP1 overexpressing MCF10A or CRL1902 cells could form tumors in mice (data not shown). BT474 tumors were excised and embedded in paraffin, and thin sections were analyzed by IHC. All of the large tumors continued to overexpress (D) The level of VEGF expression secreted into CAMs was determined by assaying equal amounts of CAM extracts by ELISA. (E) Tumor growth was determined by comparing the excised weight and volume of tumors (mg 3 mm 3 ), normalizing to the vector control tumors set at 100%. Data in all studies were derived from at least three independent experiments comprising five eggs per tumor cell line. (F) Vector control or HA-4E-BP1 overexpressing BT474 cells were implanted subcutaneously into the flank of nude mice with implantation of 60 day exogenous estrogen pellets; tumors were photographed in situ and excised at 21 days. IHC was carried out on paraffin-embedded sections. Typical results are shown.
(G) BT474 tumor cell volumes were determined at 21 days from three independent trials of eight mice per group (p < 0.001).
(H) BT474 control and 4E-BP1/eIF4G overexpressing tumors were grown in mice for 3 weeks while expressing the cap-dependent RFP/IRES-dependent GFP bicistronic reporter mRNA. Tumors were excised into OCT, and frozen sections were prepared and visualized by confocal microscopy (merged RFP/GFP image shown). Data were quantified from ten independent fields of cells and displayed as the ratio of GFP/RFP. (I) Tumor vasculature visualized by Texas red-dextran decoration of tumor vasculature endothelium. Mice were injected i.v. with stain and sacrificed 5 min later, and tumor vasculature was visualized in embedded sections by confocal microscopy and quantified. Arrows indicate blood vessels with costained erythrocytes. Standard errors of the mean were calculated from at least three independent experiments and all results achieve p < 0.05 (paired Student's t test).
4E-BP1, were strongly increased in expression of VEGF-A, and showed no change in eIF4G and eIF4E levels compared to vector controls ( Figure 5F ). Levels of cap-dependent and VEGF IRES-dependent mRNA translation were visualized in tumors by prior transfection of vector and 4E-BP1 overexpressing BT474 cells with a vector expressing the bicistronic cap-RFP/VEGF IRES-GFP mRNA, described earlier. Tumors were grown over a period of 3 weeks, excised, and visualized by confocal microscopy. The GFP/RFP ratio, which is a measure of the cap-dependent to cap-independent level of translation directed by the VEGF IRES, was quantified ( Figure  5H ). 4E-BP1 overexpressing tumors synthesized 2.5-fold higher levels of GFP, which was driven by the VEGF IRES compared to RFP driven by the cap-dependent 5 0 NCR found in vector control cells (normalized for mRNA levels). These data therefore demonstrated a switch from capdependent to IRES-directed translation during tumor growth only in tumor cells overexpressing 4E-BP1 and eIF4G. The tumor vasculature was visualized by i.v. injection of Texas-red conjugated dextran, which binds and decorates the endothelial vasculature component (Lin et al., 2006) . Analysis of tumor sections by confocal microscopy demonstrated a 3-fold increase in small blood vessel density in the 4E-BP1/eIF4G overexpressing tumors compared to controls, some of which could be seen containing erythrocytes ( Figure 5I ). Overexpression of 4E-BP1 therefore promotes increased IRES-dependent mRNA translation at the expense of cap-dependent mRNA translation and is associated with increased tumor growth and angiogenesis in an animal model.
DISCUSSION
Several key mRNAs in tumorigenesis, such as VEGF-A, Bcl2, and HIF1a, are dual translation mRNAs that can utilize cap-dependent and cap-independent (IRES) mechanisms. An important effect of hypoxia is to restrict capdependent mRNA translation (Connolly et al., 2006) . Thus, mRNAs encoding angiogenic factors (VEGF and FGF) and mediators of the hypoxia response (HIF1a), among others, must possess an alternate means for initiating translation under hypoxic conditions. It was previously shown that survival of breast tumor cells under stress conditions such as hypoxia involves increased VEGF mRNA translation via activation of the PI3K/Akt/mTOR pathway (Chung et al., 2004) . Our studies suggest that, although some of this increase is a result of HIF1a induction of VEGF transcription, selective VEGF translation is considerably increased by hypoxia activation of overexpressed 4E-BP1, with consequent reduction of cap-dependent protein synthesis and promotion of IRES-dependent mRNA translation. It was also previously shown that human chromosome position 8p11-12, which includes the 4E-BP1 gene, is amplified in some human breast and prostate cancers , possibly explaining 4E-BP1 overexpression that we observed in large tumors.
A key finding of this study is that increased expression of 4E-BP1 and eIF4G reprograms cells to trigger hypoxia-mediated angiogenesis responses at much higher levels of oxygen, through greater sequestration of eIF4E by 4E-BP1, suppression of cap-dependent, and increased IRES-mediated mRNA translation. This scenario was reciprocally associated with increased or sustained translation via the IRES in dual function mRNAs during hypoxia, including those orchestrating angiogenesis (VEGF), anti-apoptosis (Bcl2), and hypoxia (HIF1a) responses. However, translation of these same mRNAs can also be increased by cap-dependent translation through overexpression of eIF4E, which can promote tumor growth and angiogenesis as well (Gingras et al., 1999; Holcik and Sonenberg, 2005) . Indeed, collectively with our work, we suggest that there may be two pathways by which translational control may be involved in cancer progression. We suggest that increased expression of eIF4E and stronger cap-dependent mRNA translation may be one mechanism, but one that also likely requires uncoupling hypoxia inhibition of cap-dependent mRNA translation during transformation. The second pathway, suggested here, involves increased expression of 4E-BP1 and eIF4G, which promotes greater levels of IRESdependent mRNA translation during hypoxia, but functions in the absence of uncoupling of hypoxia inhibition of cap-dependent mRNA translation. The maintenance of Bcl2 expression by IRES-dependent mRNA translation under these conditions is likely critical for the development of the larger tumors observed in mice by promoting tumor cell survival. Overexpression of 4E-BP1 and eIF4G did not increase tumor cell proliferation rates (data not shown), suggesting that preservation of tumor cell viability underlies at least part of the large increase in tumor size observed in animals. Importantly, both models of translational control in cancer (cap dependent and IRES dependent) are derived largely from animal and model systems and are at this point only statistically associated with changes observed in translation factor levels in human tumor specimens.
Nevertheless, several groups have now observed elevated levels of 4E-BP1 in human prostate, head, and neck and some gastrointestinal cancers (Kremer et al., 2006; Martin et al., 2000) . The effect of 4E-BP1 overexpression in our studies is also not at odds with a report in which engineered overexpressed 4E-BP1 was found to be inhibitory to cell growth and transformation (Avdulov et al., 2004) . In those studies, the level of 4E-BP1 overexpression was much higher, which likely explains its inhibitory effect even under normoxic conditions, as 4E-BP1 at more physiological levels typically functions as a growth inhibitor only after stress activation (Teleman et al., 2005) .
Our findings support a molecular mechanism in which both cap-dependent translation driven by eIF4E and eIF4G and cap-independent (IRES-mediated) translation promoted under hypoxia by 4E-BP1 levels are required for tumor progression. eIF4E would then promote stronger translation and tumor cell proliferation in the absence of hypoxia, as has been observed for a lymphoma (nonsolid tumor) model (Wendel et al., 2004) . In solid tumors, high levels of eIF4E would also be expected to promote tumor survival and angiogenesis, particularly if hypoxia inhibition of cap-dependent mRNA translation is uncoupled either by disruption of hypoxia signaling pathways (Connolly et al., 2006) , tumor cell engagement of specific integrins such as a6B4 (Chung et al., 2004) , or other means. In contrast, elevated 4E-BP1 reduces the level of oxygen depletion required to trigger this inhibition, thereby preserving tumor cell viability and promoting strong IRES-dependent mRNA translation mediated by eIF4G.
It needs to be mentioned that 4E-BP1 activation by hypoxia in our studies is not equivalent to treatment of cells with rapamycin, an mTOR inhibitor that blocks tumor growth by functioning as an antiangiogenic agent (Del Bufalo et al., 2006; Guba et al., 2002; Thomas et al., 2006) . Rapamycin inhibition of mTOR has other effects on the cell apart from activation of 4E-BP1, including inhibition of cell growth (Ruvinsky et al., 2005) , inhibition of VEGF stimulation of vascular endothelial cells (Vinals et al., 1999; Yu et al., 2001) , impaired Akt activity (Sarbassov et al., 2006) , and G1 cell-cycle arrest (Barbet et al., 1996) . In fact, it was noted that rapamycin does not strongly downregulate VEGF production but does block expression of HIF1a at the level of transcription (Del Bufalo et al., 2006; Thomas et al., 2006) , consistent with our results ( Figure S2B ).
In summary, we have shown that overexpression of 4E-BP1 and eIF4G in model systems promotes a switch from cap-dependent to IRES-dependent translation mediated by hypoxia, resulting in selective translation of IRES-containing mRNAs such as VEGF, HIF1a, and Bcl2 that promote tumor angiogenesis and survival.
EXPERIMENTAL PROCEDURES
IHC, immunoblot, and VEGF ELISA analysis, retroviral and lentiviral expression studies, single-step real-time quantitative RT-PCR, subcutaneous xenotransplant tumor model, CAM analysis of tumor growth and angiogenesis, methionine incorporation assay, and cell lines, cell culture, antibodies, plasmids, and transfection are described in the Supplemental Experimental Procedures.
Tissue Specimens
Specimens consisted of 94 primary breast cancer specimens stages I-III, 85 of which included all factors. Specimens were obtained from archival paraffin blocks between 1996 and 2006. Breast cancer patients were aged 27-79 years and were treated at the NYU School of Medicine (NYUSM). Samples were selected as coded specimens under an HIPAA-compliant protocol approved by the NYUSM Institutional Review Board and included all tumor specimens identified as stage I-III invasive ductal carcinoma. All tumor specimens were obtained from pretreatment surgical resections (T1 and smaller T2 tumors) or pretreatment tumor core biopsies, except for immunoblot studies in Figure 1B , which were obtained from fresh posttreatment surgically resected T3 tumor specimens. Fresh normal breast tissue was obtained from mammoplasty reduction surgery. Final breast cancer diagnosis was confirmed by pathologic evaluation. Pretreatment tumor size was determined at surgical pathology (T1 and smaller T2 tumors) or clinically by caliper measurement (large T2 tumors > 4 cm and T3 tumors > 5 cm). Tissue microarrays were developed as described (Kononen et al., 1998) by using three 1.2 mm 3 4 mm thick circular punches per tumor specimen, chosen by the pathologist blinded to study design. Specimens were stained with hematoxylin and eosin (H&E) to confirm diagnoses. Each series included as controls normal breast tissue, selected common specimens to provide for consistent interpretation, and packed, sectioned cell lines engineered to over-or underexpress specific factors.
Morphometric Analysis of Tumor Vasculature
Tumor vasculature in CAM studies was made visible by staining with fluorescein isothiocyanate (FITC)-labeled Lycopersicon lectin (Vector Labs) as described (Miller et al., 2004) . Briefly, 5 mM frozen sections were fixed for 30 s in 1:1 methanol:formaldehyde, permeabilized with Triton X-100, blocked, and incubated with FITC-lectin for 1.5 hr and then slides were mounted and viewed by confocal fluorescent microscopy with a Zeiss 25M Pascal scope. The percent vascular area (Guba et al., 2002) and mean fluorescent vasculature density of the tumor were derived from the images as described (Miller et al., 2004) . In vivo vessel labeling was conducted as described (Lin et al., 2006) . Briefly, Texas red-conjugated dextran (mol wt 70,000; Molecular Probes) prepared at 6.2 mg/ml in PBS was injected by tail vein (21 mg/g weight), and mice were sacrificed 3 min later. Tumors were rapidly excised, fixed in formalin, paraffin embedded, and sectioned. Vessels were visualized by immunofluorescence microscopy.
Statistical Analysis
Statistical analysis of laboratory research results comparing differences between control and experimental groups (Figures 2-5 
